CSPC Innovation Pharmaceutical (300765.SZ) completed a repurchase of 12.002 million shares at a cost of 321 million yuan.
New Noble (300765.SZ) announcement, as of September 20, 2024, the company has completed the share repurchase through special certificates...
CSPC Innovation Pharmaceutical (300765.SZ) announced that as of September 20, 2024, the company repurchased 12.002 million shares of the company through a special securities account for share repurchase using centralized bidding trading, accounting for 0.85% of the company's current total share capital. The highest transaction price was 34.99 yuan per share, the lowest transaction price was 18.68 yuan per share, and the total amount paid was 321 million yuan (excluding transaction costs). The buyback period has expired, and the buyback plan has been completed.
Related Articles

HK Stock Market Move | HKBN (01310) surges more than 15% yesterday, soaring over 68%. China Mobile Hong Kong's tender offer for shares rises to 78.08%.

HK Stock Market Move | ANTA SPORTS (02020) rose nearly 5% during trading hours. The company is fully committed to advancing its globalization strategy and plans to open thousands of stores in Southeast Asia in the next three years.

HK Stock Market Move | CONGYU INTE AGR(00875) rose more than 5%, the company deepens the integration of low-altitude economy and digital agriculture, and increases investment in the Jiangsu Nonghua Intelligent Agriculture Technology sector.
HK Stock Market Move | HKBN (01310) surges more than 15% yesterday, soaring over 68%. China Mobile Hong Kong's tender offer for shares rises to 78.08%.

HK Stock Market Move | ANTA SPORTS (02020) rose nearly 5% during trading hours. The company is fully committed to advancing its globalization strategy and plans to open thousands of stores in Southeast Asia in the next three years.

HK Stock Market Move | CONGYU INTE AGR(00875) rose more than 5%, the company deepens the integration of low-altitude economy and digital agriculture, and increases investment in the Jiangsu Nonghua Intelligent Agriculture Technology sector.

RECOMMEND

Three-Year R&D Spend Drains RMB 2.4 Billion, Urgent Cash Needs Drive Maiwei Biotech Back to Hong Kong Amid Compliance Scrutiny
18/09/2025

Why Generating Profit Remains Challenging for Lidar Companies
18/09/2025

SEC Adopts Landmark Rule to Restrict Shareholder Class Actions in Bid to Revive IPO Market
18/09/2025